For example, increased secretion of CXCL5 in prostate cancers is known to recruit MDSCs and Treg cells to the tumor microenvironment, which blocks cytotoxic T cell activity and protects tumor cells from T cell-mediated cell death [113]. Here, CXCL5 is linked to prostate carcinoma.